Inclusion Criteria:  The subject's legally authorized representative has been informed of the nature of the- clinical investigation, agrees to its provisions, and has provided written informed consent  Requiring treatment of:  native or recurrent aortic coarctation, and/or native or recurrent pulmonary artery stenosis Vascular stenosis measuring < or equal to 50% of normal adjacent vessel Patency of at least one femoral vein, femoral artery, jugular vein or both carotid arteries able to accommodate the delivery system Adjacent vessel to stenosis measuring > or equal to 4 mm  Exclusion Criteria:  Active bloodstream infection requiring antibiotic therapy within 3 days prior to stent implantation History of or active endocarditis (active treatment with antibiotics) within 180 days prior to stent implantation Aortic or pulmonary artery aneurysm in close proximity to the target lesion Body weight of < 1.5 kg Anatomic location of lesion judged by the investigator to not lend to the safe placement of a stent Target vessels larger or smaller than the Minima System balloon size ranges Currently participating in an investigational drug study or another device study Major or progressive non-cardiac disease resulting in a life expectancy of less than six months Known hypersensitivity to aspirin or heparin and cannot be treated with other antiplatelet and/or antithrombotic medications Known hypersensitivity to cobalt-chromium or contrast media that cannot be adequately pre-medicated